Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF

Summary

This study is a randomized, double-blind, placebo-controlled trial in which eligible IPF subjects will be randomized to receive GBT440 or Placebo orally daily.

Timeline

Start

2016-06

Primary completion

2017-09

Completion

2017-11

Drugs

Indications